Processing and MHC class I presentation of human cytomegalovirus pp65-derived peptides persist despite gpUS2-11-mediated immune evasion

Journal of General Virology

Volumn 88, Issue 5, 2007, Pages 1429-1439

  Besold, Katrin ^a   Frankenberg, Nadine ^a,c   Pepperl Klindworth, Sandra ^a   Kuball, Jürgen ^a,d   Theobald, Matthias ^a   Hahn, Gabriele ^b,e   Plachter, Bodo ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c NOVARTIS PHARMA AG   (Switzerland)

^d Fred Hutchinson Cancer Research Center   (United States)

^e Bioscientia Hamburg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYTOMEGALOVIRUS ANTIGEN PP65; GLYCOPROTEIN; GLYCOPROTEIN GP 100; GLYCOPROTEIN GP US10; GLYCOPROTEIN GP US11; GLYCOPROTEIN GP US2; GLYCOPROTEIN GP US3; GLYCOPROTEIN GP US4; GLYCOPROTEIN GP US5; GLYCOPROTEIN GP US6; GLYCOPROTEIN GP US7; GLYCOPROTEIN GP US8; GLYCOPROTEIN GP US9; IMMEDIATE EARLY PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTIGENIC VARIATION; ARTICLE; CELL SPECIFICITY; CELL VIABILITY; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNE RESPONSE; MESSENGER RNA SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; VIRUS REPLICATION; VIRUS VIRULENCE;

HUMAN HERPESVIRUS 5;

EID: 34248157814     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82686-0     Document Type: Article

References (64)

1. Ahn, K., Angulo, A., Ghazal, P., Peterson, P. A., Yang, Y. & Früh, K. (1996). Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci U S A 93, 10990-10995.
2. Ahn, K., Gruhler, A., Galocha, B., Jones, T. R., Wiertz, E. J., Ploegh, H. L., Peterson, P. A., Yang, Y. & Früh, K. (1997). The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6, 613-621.
3. + T cells by dendritic cells. J Virol 74, 10018-10024.
4. Barnes, P. D. & Grundy, J. E. (1992). Down-regulation of the class I HLA heterodimer and beta 2-microglobulin on the surface of cells infected with cytomegalovirus. J Gen Virol 73, 2395-2403.
5. Benz, C. & Hengel, H. (2000). MHC class I-subversive gene functions of cytomegalovirus and their regulation by interferons - an intricate balance. Virus Genes 21, 39-47.
6. Bunde, T., Kirchner, A., Hoffmeister, B., Habedank, D., Hetzer, R., Cherepnev, G., Proesch, S., Reinke, P., Volk, H. D. & other authors (2005). Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J Exp Med 201, 1031-1036.
7. Chee, M. S., Bankier, A. T., Beck, S., Bohni, R., Brown, C. M., Cerny, R., Horsnell, T., Hutchison, C. A., Kouzarides, T. & other authors (1990). Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol 154, 125-169.
8. Cherepanov, P. P. & Wackernagel, W. (1995). Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 158, 9-14.
9. Cobbold, M., Khan, N., Pourgheysari, B., Tauro, S., McDonald, D., Osman, H., Assenmacher, M., Billingham, L., Steward, C. & other authors (2005). Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J Exp Med 202, 379-386.
10. + T lymphocytes. Mol Immunol 39, 235-247.
11. Depto, A. S. & Stenberg, R. M. (1989). Regulated expression of the human cytomegalovirus pp65 gene: octamer sequence in the promoter is required for activation by viral gene products. J Virol 63, 1232-1238.
12. Diamond, D. J., York, J., Sun, J. Y., Wright, C. L. & Forman, S. J. (1997). Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection. Blood 90, 1751-1767.
13. +-T-cell responses to human cytomegalovirus reveals broad and multi-specific reactivities in healthy virus carriers. J Virol 77, 5226-5240.
14. Falk, C. S., Mach, M., Schendel, D. J., Weiss, E. H., Hilgert, I. & Hahn, G. (2002). NK cell activity during human cytomegalovirus infection is dominated by US2-11-mediated HLA class I down-regulation. J Immunol 169, 3257-3266.
15. Frankenberg, N., Pepperl-Klindworth, S., Meyer, R. G. & Plachter, B. (2002). Identification of a conserved HLA-A2-restricted decapeptide from the IE1 protein (pUL123) of human cytomegalovirus. Virology 295, 208-216.
16. Gallez-Hawkins, G, Villacres, M. C., Li, X., Sanborn, M. C., Lomeli, N. A. & Zaia, J. A. (2003). Use of transgenic HLA A*0201/ Kb and HHD II mice to evaluate frequency of cytomegalovirus IE1-derived peptide usage in eliciting human CD8 cytokine response. J Virol 77, 4457-4462.
17. + T lymphocytes in healthy seropositive donors. J Virol 74, 8140-8150.
18. Gil-Torregrosa, B. C., Castano, A. R., Lopez, D. & Del, V. M. (2000). Generation of MHC class I peptide antigens by protein processing in the secretory route by furin. Traffic 1, 641-651.
19. Gromme, M., Uytdehaag, F. G., Janssen, H., Calafat, J., van Binnendijk, R. S., Kanter, M. J., Tulp, A., Verwoerd, D. & Neefjes, J. (1999). Recycling MHC class I molecules and endosomal peptide loading. Proc Natl Acad Sci U S A 96, 10326-10331.
20. Halenius, A., Momburg, F., Reinhard, H., Bauer, D., Lobigs, M. & Hengel, H. (2006). Physical and functional interactions of the cytomegalovirus US6 glycoprotein with the transporter associated with antigen processing. J Biol Chem 281, 5383-5390.
21. Hengel, H., Koopmann, J. O., Flohr, T., Muranyi, W., Goulmy, E., Hammerling, G. J., Koszinowski, U. H. & Momburg, F. (1997). A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6, 623-632.
22. Hobom, U., Brune, W., Messerle, M., Hahn, G. & Koszinowski, U. H. (2000). Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes. J Virol 74, 7720-7729.
23. Holtappels, R., Podlech, J., Pahl-Seibert, M. F., Jülch, M., Thomas, D., Simon, C. O., Wagner, M. & Reddehase, M. J. (2004). Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues. J Exp Med 199, 131-136.
24. Irmiere, A. & Gibson, W. (1983). Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus. Virology 130, 118-133.
25. Jondal, M., Schirmbeck, R. & Reimann, J. (1996). MHC class I-restricted CTL responses to exogenous antigens. Immunity 5, 295-302.
26. Jones, T. R., Hanson, L. K, Sun, L., Slater, J. S., Stenberg, R. M. & Campbell, A. E. (1995). Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J Virol 69, 4830-4841.
27. Jones, T. R., Wiertz, E. J., Sun, L., Fish, K. N., Nelson, J. A. & Ploegh, H. L. (1996). Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci U S A 93, 11327-11333.
28. Kambayashi, T., Kraft-Leavy, J. R., Dauner, J. G., Sullivan, B. A., Laur, O. & Jensen, P. E. (2004). The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes. J Immunol 172, 1661-1669.
29. + -T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited. J Virol 73, 8179-8184.
30. Khan, N., Cobbold, M., Keenan, R. & Moss, P. A. (2002). Comparative analysis of CD8 + T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype. J Infect Dis 185, 1025-1034.
31. Khan, N., Bruton, R., Taylor, G. S., Cobbold, M., Jones, T. R., Rickinson, A. B. & Moss, P. A. (2005). Identification of cytomegalovirus-specific cytotoxic T lymphocytes in vitro is greatly enhanced by the use of recombinant virus lacking the US2 to US11 region or modified vaccinia virus Ankara expressing individual viral genes. J Virol 79, 2869-2879.
32. Kloetzel, P. M. (2004). Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII. Nat Immunol 5, 661-669.
33. Lee, E. C., Yu, D., Martinez de Velasco, J., Tessarollo, L., Swing, D. A., Court, D. L., Jenkins, N. A. & Copeland, N. G. (2001). A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73, 56-65.
34. Lehner, P. J., Karttunen, J. T., Wilkinson, G. W. & Cresswell, P. (1997). The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc Natl Acad Sci U S A 94, 6904-6909.
35. + cytotoxic T-cell response in natural infection. Blood 104, 1075-1082.
36. McLaughlin-Taylor, E., Pande, H., Forman, S. J., Tanamachi, B., Li, C. R., Zaia, J. A., Greenberg, P. D. & Riddell, S. R. (1994). Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8 + virus-specific cytotoxic T lymphocytes. J Med Virol 43, 103-110.
37. + T cells using an ELISPOT assay. J Immunol Methods 181, 45-54.
38. Mocarski, E. S. (2004). Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system. Cell Microbiol 6, 707-717.
39. Pahl-Seibert, M. F., Jülch, M., Podlech, J., Thomas, D., Deegen, P., Reddehase, M. J. & Holtappels, R. (2005). Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sorting. J Virol 79, 5400-5413.
40. Park, B., Kim, Y., Shin, J., Lee, S., Cho, K., Fruh, K., Lee, S. & Ahn, K. (2004). Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. Immunity 20, 71-85.
41. Park, B., Lee, S., Kim, E., Cho, K., Riddell, S. R., Cho, S. & Ahn, K. (2006). Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing. Cell 127, 369-382.
42. Pass, R. F. (2001). Cytomegalovirus. In Fields Virology, 4th edn, pp. 2675-2705. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
43. Pepperl, S., Münster, J., Mach, M., Harris, J. R. & Plachter, B. (2000). Dense bodies of human cytomegalovirus induce both humoral and cellular immune responses in the absence of viral gene expression. J Virol 74, 6132-6146.
44. Pepperl-Klindworth, S., Frankenberg, N., Riegler, S. & Plachter, B. (2003). Protein delivery by subviral particles of human cytomegalovirus. Gene Ther 10, 278-284.
45. Plachter, B. (1999). Immunevasion during cytomegalovirus infection. Biomed Progr 12, 71-74.
46. + T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants. Blood 103, 3565-3572.
47. Reddehase, M. J. (2000). The immunogenicity of human and murine cytomegaloviruses. Curr Opin Immunol 12, 390-396.
48. Reddehase, M. J. (2002). Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance. Nat Rev Immunol 2, 831-844.
49. Reddehase, M. J., Weiland, F., Münch, K., Jonjic, S., Luske, A. & Koszinowski, U. H. (1985). Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J Virol 55, 264-273.
50. Reddehase, M. J., Mutter, W., Münch, K., Buhring, H. J. & Koszinowski, U. H. (1987). CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol 61, 3102-3108.
51. Reusser, P., Riddell, S. R., Meyers, J. D. & Greenberg, P. D. (1991). Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78, 1373-1380.
52. Riddell, S. R., Watanabe, K. S., Goodrich, J. M., Li, C. R., Agha, M. E. & Greenberg, P. D. (1992). Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257, 238-241.
53. Sigal, L. J., Crotty, S., Andino, R. & Rock, K. L. (1999). Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 398, 77-80.
54. Simon, C. O., Holtappels, R., Tervo, H. M., Böhm, V., Daubner, T., Oehrlein-Karpi, S. A., Kühnapfel, B., Renzaho, A., Strand, D. & other authors (2006). CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation. J Virol 80, 10436-10456.
55. Sugawara, S., Abo, T. & Kumagai, K. (1987). A simple method to eliminate the antigenicity of surface class I MHC molecules from the membrane of viable cells by acid treatment at pH 3. J Immunol Methods 100, 83-90.
56. + T cells dominate the memory compartments of exposed subjects. J Exp Med 202, 673-685.
57. Theobald, M., Biggs, J., Dittmer, D., Levine, A. J. & Sherman, L. A. (1995). Targeting p53 as a general tumor antigen. Proc Natl Acad Sci U S A 92, 11993-11997.
58. Varnum, S. M., Streblow, D. N., Monroe, M. E., Smith, P., Auberry, K. J., Pasa-Tolic, L., Wang, D., Camp, D. G., Rodland, K. & other authors (2004). Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol 78, 10960-10966.
59. Walter, E. A., Greenberg, P. D., Gilbert, M. J., Finch, R. J., Watanabe, K. S., Thomas, E. D. & Riddell, S. R. (1995). Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 333, 1038-1044.
60. Wiertz, E. J., Jones, T. R., Sun, L., Bogyo, M., Geuze, H. J. & Ploegh, H. L. (1996a). The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84, 769-779.
61. Wiertz, E. J., Tortorella, D., Bogyo, M., Yu, J., Mothes, W., Jones, T. R., Rapoport, T. A. & Ploegh, H. L. (1996b). Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384, 432-438.
62. Wills, M. R., Carmichael, A. J., Mynard, K., Jin, X., Weekes, M. P., Plachter, B. & Sissons, J. G. (1996). The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol 70, 7569-7579.
63. Wills, M. R., Carmichael, A. J. & Sissons, J. G. (2006). Adaptive cellular immunity to human cytomegalovirus. In Cytomegalovirus: Molecular Biology and Immunology, pp. 341-365. Edited by M. J. Reddehase. Norwich, UK: Caister Academic Press.
64. Yu, Z., Theoret, M. R., Touloukian, C. E., Surman, D. R., Garman, S. C., Feigenbaum, L., Baxter, T. K., Baker, B. M. & Restifo, N. P. (2004). Poor immunogenicity of a self/tumor antigen derives from peptide-MHC-I instability and is independent of tolerance. J Clin Invest 114, 551-559.